MYDECINE
Creating a healthier world through adaptive pathway medicines, natural health products and digital health solutions
Leveraging partnerships with scientific, medical, military, and clinical organizations, Mydecine is at the forefront of psychedelic medicine.

Our Mission

Our mission is to create a healthier world through advanced technologies, natural products, and psychedelic derived medicines. We were founded on the belief that innovation is needed to improve on existing products and mental health services. Our goal is to change the way you think about holistic health by delivering premium quality products and services that enhance your life.

Our Story

We started Mydecine Innovation with the goal of revolutionizing the way people live and experience life by offering cutting edge natural products and technologies. Our international team has been described as a collection of passionate business leaders, scientists, mental health professionals and technology visionaries.

We are inspired by the future, the innovators, the dreamers; and our products embody this  spirit. They are built for those that aspire to be healthy physically and spiritually while living life to the fullest and daring to disrupt the norm.

Our passion sent us on a mission to develop high quality products and disruptive new technologies so we can contribute to making the world a better place.
---VIDEO---

About Us

Mydecine Innovations Group is a life sciences company dedicated to the development and commercialization of adaptive pathway medicines, natural health products and digital health solutions.

Currently Mydecine Innovations Group encompasses three companies, each with its own unique vertical focus and core strengths that position it to be a market leader. Collectively these companies also act as an integrated entity that is greater than the sum of its parts, both in output and impact.
Mydecine Health Sciences Logo
NeuroPharm Inc. (NPI) is developing a unique and proprietary set of pharmaceutical and natural health products addressing mental wellness in vulnerable populations.
Learn MoreLearn More
Mindleap is an advanced digital health platform that helps people connect with mental health specialists who can empower them to thrive and develop habits for a healthy mind.
Mydecine Health Sciences (MHS) is a vertically integrated company developing novel fungtional© mushroom products and psychedelic medicines for healthy and vulnerable populations.
Learn More

Our Portfolio

Natural Health Products
Learn More→
We are discovering, extracting, and combining powerful fungtional© and psychedelic ingredients in mushrooms to enhance and balance the brain.
Research & Development
We are charting new paths with Neurological Disorder Medicines based on the novel compounds found in psychedelic medicines.
Learn More→
Learn More→Digital Health Solutions
We are developing breakthrough digital technologies to augment mental healthcare with data, digital therapeutics, and global connectivity.

Our Portfolio

Natural Health Products
Learn More→
We are discovering, extracting, and combining powerful fungtional© and psychedelic ingredients in mushrooms to balance and enhance the brain.
Research & Development
We are charting new paths with Neurological Disorder Medicines based on the novel compounds found in psychedelic medicines.
Learn More→
Learn More→Digital Health Solutions
We are developing breakthrough digital technologies to augment mental healthcare with data, digital therapeutics, and global connectivity.

Our Story

We started Mydecine Innovations Group with the goal of revolutionizing the way people live and experience life by offering cutting edge natural products and technologies. Our international team has been described as a collection of passionate business leaders, scientists, mental health professionals and technology visionaries.

We are inspired by the future, the innovators, the dreamers; and our products embody this  spirit. They are built for those that aspire to be healthy physically and spiritually while living life to the fullest and daring to disrupt the norm.

Our passion sent us on a mission to develop high quality products and disruptive new technologies so we can contribute to making the world a better place.
---VIDEO COMING SOON---

Our Brands

Mydecine is our core brand. We started Mydecine Innovation with the goal of revolutionizing the way people live and experience life by offering cutting edge natural products and technologies. Our international team has been described as a collection of passionate business leaders, scientists, mental health professionals and technology visionaries.
Kured was started with the goal of revolutionizing the way people live and experience life by offering cutting edge natural products and technologies. Our international team has been described as a collection of passionate business leaders, scientists, mental health professionals and technology visionaries.
Fresh CBD Water is infused with CBD, a naturally occurring cannabinoid in hemp, that has shown to have effects that include analgesic, anti-inflammatory, anti-oxidant, anti-emetic, anti-anxiety, anti-psyc
Mindleap Health was founded by purpose-driven leaders on a mission to enhance the wellbeing of millions of people that struggle with mental health problems. By combining traditional telemedicine, psychedelic medicine and advanced mood and behavior tracking and analytics, the Mindleap platform offers a powerful set of tools for managing mental healthcare.

For Investors

Ticker Symbols
CSX: MYCO
OTC: MYCOF
FRANKFURT: 0NF
SEDAR ProfileInvestor Presentation
1d
5d
1m
6m
ytd
1y
5y
See All News →

Ex-Canopy Growth Geneticist Turns His Focus to Psychedelics

July 29, 2020
Recently it was announced that ebbu's Director of Research, Robert Roscow, M.A., would leave a cannabis industry conglomerate to become the Chief Science Officer of the leading psychedelic startup ...
Read More →

Mydecine Innovations Group Inc. Appoints Previous Red Bull Sports Marketing Director Jim Gunning as CMO

July 24, 2020
Mydecine Innovations Group Inc. is pleased to announce that they have hired former Red Bull marketing executive, Jim Gunning, as the Company’s new Chief Marketing Officer (“CMO”).
Read More →

Psychedelic Compounds Could be Used in Mental Healthcare

July 15, 2020
There is a need for new antidepressants with a mechanism of action different from that of SSRIs and SNRIs to improve efficacy across several symptoms
Read More →
News & Media